Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 400

Similar articles for PubMed (Select 19242081)

1.

Dietary factors and cancer chemoprevention: an overview of obesity-related malignancies.

Murthy NS, Mukherjee S, Ray G, Ray A.

J Postgrad Med. 2009 Jan-Mar;55(1):45-54. Review.

2.

Energy balance, physical activity, and cancer risk.

Fair AM, Montgomery K.

Methods Mol Biol. 2009;472:57-88. doi: 10.1007/978-1-60327-492-0_3. Review.

PMID:
19107429
3.

Obesity and cancer.

Pischon T, Nöthlings U, Boeing H.

Proc Nutr Soc. 2008 May;67(2):128-45. doi: 10.1017/S0029665108006976. Review.

PMID:
18412987
4.

Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence.

Barb D, Williams CJ, Neuwirth AK, Mantzoros CS.

Am J Clin Nutr. 2007 Sep;86(3):s858-66. Review.

6.

Insulin, leptin, and adiponectin receptors in colon: regulation relative to differing body adiposity independent of diet and in response to dimethylhydrazine.

Drew JE, Farquharson AJ, Padidar S, Duthie GG, Mercer JG, Arthur JR, Morrice PC, Barrera LN.

Am J Physiol Gastrointest Liver Physiol. 2007 Oct;293(4):G682-91. Epub 2007 Jul 26.

7.

Obesity and prostate cancer: a role for adipokines.

Mistry T, Digby JE, Desai KM, Randeva HS.

Eur Urol. 2007 Jul;52(1):46-53. Epub 2007 Mar 26. Review.

PMID:
17399889
8.

Role of adipokines in complications related to obesity: a review.

Gnacińska M, Małgorzewicz S, Stojek M, Łysiak-Szydłowska W, Sworczak K.

Adv Med Sci. 2009;54(2):150-7. doi: 10.2478/v10039-009-0035-2. Review.

PMID:
19875356
9.

Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases.

Tilg H, Moschen AR.

Clin Sci (Lond). 2008 Feb;114(4):275-88. doi: 10.1042/CS20070196. Review.

10.
11.

Dietary cancer and prevention using antimutagens.

Ferguson LR, Philpott M, Karunasinghe N.

Toxicology. 2004 May 20;198(1-3):147-59. Review.

PMID:
15138038
12.

The new adipose tissue and adipocytokines.

Bulcão C, Ferreira SR, Giuffrida FM, Ribeiro-Filho FF.

Curr Diabetes Rev. 2006 Feb;2(1):19-28. Review.

PMID:
18220614
13.

Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases.

Yamauchi T, Kadowaki T.

Int J Obes (Lond). 2008 Dec;32 Suppl 7:S13-8. doi: 10.1038/ijo.2008.233. Review.

PMID:
19136982
14.

Obesity, type 2 diabetes and risk of digestive cancer.

Hillon P, Guiu B, Vincent J, Petit JM.

Gastroenterol Clin Biol. 2010 Oct;34(10):529-33. doi: 10.1016/j.gcb.2010.07.021. Review.

15.

Adipose tissue dysfunction in obesity.

Blüher M.

Exp Clin Endocrinol Diabetes. 2009 Jun;117(6):241-50. doi: 10.1055/s-0029-1192044. Epub 2009 Apr 8. Review.

PMID:
19358089
16.

Obesity and cancer: the role of dysfunctional adipose tissue.

van Kruijsdijk RC, van der Wall E, Visseren FL.

Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2569-78. doi: 10.1158/1055-9965.EPI-09-0372. Epub 2009 Sep 15. Review.

17.

[Influence of leptin and adiponectin on prostate cancer].

Lopez Fontana CM, Maselli Artola ME, Di Milta Monaco N, Recalde Rincon GM, Vanrell Rodriguez MC, Uvilla Recupero A, Messina Lombino D, Perez Elizalde RF, Lopez Laur JD.

Arch Esp Urol. 2009 Mar;62(2):103-8. Review. Spanish.

PMID:
19448276
18.

[Leptin to adiponectin ratio, as an index of insulin resistance and atherosclerosis development].

Kieć-Klimczak M, Malczewska-Malec M, Huszno B.

Przegl Lek. 2008;65(12):844-9. Polish.

PMID:
19441676
19.

Obesity and diabetes epidemics: cancer repercussions.

Hjartåker A, Langseth H, Weiderpass E.

Adv Exp Med Biol. 2008;630:72-93. Review.

PMID:
18637486
20.

Avoidable cancers in the Nordic countries. Diet, obesity and low physical activity.

Winther JF, Dreyer L, Overvad K, Tjønneland A, Gerhardsson de Verdier M.

APMIS Suppl. 1997;76:100-19. Review.

PMID:
9462823
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk